DK0966455T3 - Oxirancarboxylsyrer til behandling af diabetes - Google Patents

Oxirancarboxylsyrer til behandling af diabetes

Info

Publication number
DK0966455T3
DK0966455T3 DK98909391T DK98909391T DK0966455T3 DK 0966455 T3 DK0966455 T3 DK 0966455T3 DK 98909391 T DK98909391 T DK 98909391T DK 98909391 T DK98909391 T DK 98909391T DK 0966455 T3 DK0966455 T3 DK 0966455T3
Authority
DK
Denmark
Prior art keywords
treatment
diabetes
oxiran
carboxylic acids
aryloxyalkyl
Prior art date
Application number
DK98909391T
Other languages
English (en)
Inventor
Horst P O Dr Wolf
Ag Gesellschaft Fuer Medigene
Original Assignee
Horst P O Dr Wolf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horst P O Dr Wolf filed Critical Horst P O Dr Wolf
Application granted granted Critical
Publication of DK0966455T3 publication Critical patent/DK0966455T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98909391T 1997-02-14 1998-02-05 Oxirancarboxylsyrer til behandling af diabetes DK0966455T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19705718A DE19705718A1 (de) 1997-02-14 1997-02-14 Neue Oxirancarbonsäuren zur Behandlung des Diabetes Typ 2 und anderer insulinresistenter Zustände

Publications (1)

Publication Number Publication Date
DK0966455T3 true DK0966455T3 (da) 2004-05-17

Family

ID=7820279

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98909391T DK0966455T3 (da) 1997-02-14 1998-02-05 Oxirancarboxylsyrer til behandling af diabetes

Country Status (10)

Country Link
US (2) US6479676B1 (da)
EP (1) EP0966455B1 (da)
JP (1) JP3357378B2 (da)
AT (1) ATE258550T1 (da)
AU (1) AU6394698A (da)
CA (1) CA2280960C (da)
DE (2) DE19705718A1 (da)
DK (1) DK0966455T3 (da)
PT (1) PT966455E (da)
WO (1) WO1998035952A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056947B2 (en) * 2002-07-05 2006-06-06 Georgia Tech Research Corp. Aza-peptide epoxides
US8013014B2 (en) * 2002-07-05 2011-09-06 Georgia Tech Research Corporation Aza-peptide epoxides
CN1964630A (zh) 2003-02-13 2007-05-16 耶希瓦大学艾伯塔·爱恩斯坦医学院 通过控制下丘脑的长链脂肪酰基－辅酶A(LC－CoA)的水平来调控食物摄取和葡萄糖产生
WO2005080353A1 (en) * 2004-02-18 2005-09-01 Georgia Tech Research Corporation Propenoyl hydrazides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3063144D1 (en) * 1979-09-07 1983-06-16 Byk Gulden Lomberg Chem Fab Substituted oxirane carboxylic acids, process for their preparation, their use and medicines containing them
US4337267A (en) 1980-08-25 1982-06-29 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenalkoxyalkyl- and phenoxyalkyl-substituted oxiranecarboxylic acids, their use and medicaments containing them
IL66365A0 (en) 1981-07-24 1982-11-30 Byk Gulden Lomberg Chem Fab Phenylalkyloxiranecarboxylic acids,a process for their preparation,their use,and medicaments containing them
EP0231367B1 (de) * 1985-08-02 1991-07-24 Wolf, Horst P.O., Dr. Verwendung von oxirancarbonsäuren zur behandlung der hyperlipämie
US4788306A (en) 1987-04-03 1988-11-29 American Home Products Corporation Fluorooxirane carboxylates as hypoglycemic agents
US4788304A (en) * 1987-12-07 1988-11-29 American Home Products Corporation Phospholipase A2 inhibitors
GB9209628D0 (en) * 1992-05-05 1992-06-17 Smithkline Beecham Plc Compounds
US6013666A (en) * 1996-07-02 2000-01-11 Sang Sup Jew Oxirane carboxylic acid derivative and its manufacturing method

Also Published As

Publication number Publication date
ATE258550T1 (de) 2004-02-15
WO1998035952A1 (de) 1998-08-20
US20020198382A1 (en) 2002-12-26
US6479676B1 (en) 2002-11-12
EP0966455A1 (de) 1999-12-29
JP2000509726A (ja) 2000-08-02
PT966455E (pt) 2004-08-31
US6670481B2 (en) 2003-12-30
EP0966455B1 (de) 2004-01-28
DE59810675D1 (de) 2004-03-04
JP3357378B2 (ja) 2002-12-16
CA2280960A1 (en) 1998-08-20
AU6394698A (en) 1998-09-08
CA2280960C (en) 2007-04-17
DE19705718A1 (de) 1998-08-20

Similar Documents

Publication Publication Date Title
TNSN04039A1 (en) Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar-activators
FI961809A0 (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
DK0687268T3 (da) Spiroazacykliske derivater som substans P-antagonister
DE69217945D1 (de) Azanorbornanderivate
BR9808998A (pt) Imidazóis substituìdos úteis no tratamento de doenças inflamatórias
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
CA2331395A1 (en) Fatty acid analogues for the treatment of diabetes
ATE165827T1 (de) Herstellung von n-acetylneuraminsäure-derivaten
EA200400708A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
GR3034821T3 (en) New 6-hydroxy and 6-oxo-anstro-stane derivatives active on the cardiovascular system and pharmaceutical compositions containing same
TR199901486T2 (xx) Alfa-2 adrenosept�r agonistleri olarak yararl� 2-imidazolinilamino-benzoksazol bile�ikleri.
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
DK0966455T3 (da) Oxirancarboxylsyrer til behandling af diabetes
DK0938584T3 (da) Fremgangsmåde til fremstilling af (S)-eller (R)-3,3,3-trifluor-2-hydroxy-2-methylpropionsyre
RU94038063A (ru) 3-фенилуреидо-азепин-2-оны и -бензазепин-2-оны, способы их получения, промежуточные соединения, фармацевтические композиции и способы лечения
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
DK1133314T3 (da) Protein C til behandling af seglcellesygdom og thalassæmi
TR200400907T4 (tr) Beta D 5-Tiyoksiloz türevleri, bunları hazırlama yöntemi ve bunların terapötik kullanımları
TR199901542T2 (xx) Alfa-2 adrenosept�r agonistleri olarak yararl� 2-imidazolinilaminoindazol bile�ikleri.
PL369295A1 (en) Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
PT1232173E (pt) Derivados do acido fusidico
DK0777663T3 (da) Anvendelse af substituerede 6-amino-4H-pyraner
AU2910800A (en) Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
IT1258788B (it) Derivati solforati di acidi biliari
ES2105815T3 (es) Nuevos derivados de hidrazino- e hidroxiamino-14beta-hidroxiandrostano activos sobre el sistema cardiovascular, procesos para su preparacion y composiciones farmaceuticas que contienen los mismos.